.png "Zimmer Biomet Holdings (NYSE: ZBH)")
Yesterday, the Sr. VP of Zimmer Biomet Holdings (ZBH), Chad Phipps, sold shares of ZBH for $967.9K.
Following Chad Phipps’ last ZBH Sell transaction on August 15, 2019, the stock climbed by 4.3%.
See today’s analyst top recommended stocks >>
The company has a one-year high of $140.53 and a one-year low of $96.99.
The insider sentiment on Zimmer Biomet Holdings has been negative according to 29 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Zimmer Biomet Holdings, Inc. provides musculoskeletal healthcare services. It designs, manufactures and markets orthopedic reconstructive products, sports medicine, biologics, extremities & trauma products, office based technologies, spine, craniomaxillofacial & thoracic products, dental implants and related surgical products.
